CnT-17 Airway Epithelial Proliferation Medium
Product Code:
CnT-17
CnT-17
Regulatory Status:
RUO
RUO
Target Species:
- Human
- Mouse
Shipping:
Dry ice
Dry ice
Storage:
Media: 2°C to 8°C, protect from light. Supplements: Below -15°C
Media: 2°C to 8°C, protect from light. Supplements: Below -15°C
No additional charges, what you see is what you pay! *
Code | Size | Price |
---|
CnT-17 | 500 mL | £317.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Media kit. Comprised of basal medium with separate supplements. Must be shipped in 2 boxes. |
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Switzerland.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
- Further Information
- Documents
- References
- Related Products
- Show All
Further Information
Animal and Human Component-Free?:
No
Application:
Isolation & Expansion
Chemically Defined?:
Yes
Clinically Upgradable?:
Yes
Component(s):
Basal Medium & Supplement Pack
Contains Bovine Pituitary Extract (BPE)?:
No
Contains Serum?:
No
Description:
CnT-17 is a fully defined medium for isolation and exapansion of large airway epithelial cells.
Quality Level:
Research Grade
Species to be used on:
Human & Mouse
Tissue Type:
Airway epithelial cells
References
- Petra Khan, 2018. Culture of human alveolar epithelial type II cells by sprouting. Journal: Respiratory Research. Authors: Petra Khan, Kleanthis Fytianos, Luca Tam?, Michael Roth, Michael Tamm, Thomas Geiser, Amiq Gazdhar, Katrin?E?Hostettler. Basel, Switzerland .
- Antoine Guillon, 2018. Inactivation of the interleukin-22 pathway in the airways of cystic fibrosis patients. Journal: Cytokine. Authors: Antoine Guillon, Deborah Brea , Emilie Luczka, Virginie Herv?, Soujoud Hasanat, Camille Thorey, Magdiel P?rez-Cruz, Juliette Hordeaux, Julie Mankikian, Philippe Gosset, Christelle Coraux, Mustapha Si-Tahar. Tours, France.
- Aline Sch?gler, 2019. Modulation of the unfolded protein response pathway as an antiviral approach in airway epithelial cells. Journal: Antiviral Research. Authors: Aline Sch?gler, Oliver Caliaro, Melanie Br?gger, Blandina I. Oliveira Esteves, Izabela Nita, Amiq Gazdhar, Thomas Geiser, Marco P. Alves. Bern, Switzerland .
- Fabiana C. P. Valera, 2018. Staphylococcus aureus impairs sinonasal epithelial repair: Effects in patients with chronic rhinosinusitis with nasal polyps and control subjects. Journal: The Journal of Allergy and Clinical Immunology. Authors: Fabiana C. P. Valera, Manon Ruffin, Damien Adam, Emilie Maill?, Badr Ibrahim, Julie Berube, Simon Rousseau, Emmanuelle Brochiero, Martin Y. Desrosiers. Montreal, Canada.
- Maximilian Boesch, 2020. Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis. Journal: Respiratory Research. Authors: Maximilian Boesch, Florent Baty, Martin H. Brutsche, Michael Tamm, Julien Roux, Lars Knudsen, Amiq Gazdhar, Thomas Geiser, Petra Khan, Katrin E. Hostettler . Basel, Switzerland.
- Yu-Zhi Lu, 2020. Bleomycin induced apical-basal polarity loss in alveolar epithelial cell contributes to experimental pulmonary fibrosis. Journal: Experimental Cell Research. Authors: Yu-Zhi Lu, Xin-Liang He, Fei Liu, Pei-Pei Cheng, Li-Mei Liang, Meng Wang, Shuai-Jun Chen, Yi Huang, Fan Yu, Jian-Bao Xin, Hong Ye, Lin-Ji Song, Wan-Li Maa. Wuhan, China.
- Katarzyna Bogucka, 2020. ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis. Journal: Cancer Gene Therapy. Authors: Katarzyna Bogucka, Federico Marini, Sebastian Rosigkeit, Janine Schloeder, Helmut Jonuleit, Kerstin David, Margarita Schlackow, Krishnaraj Rajalingam . Mainz, Germany.
- Kristina Riegel, 2021. ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppression. Journal: Cell Death Dis. Authors: Kristina Riegel, Hajime Yurugi, Janine Schl?der, Helmut Jonuleit, Manuel Kaulich, Friederike Kirschner, Danielle Arnold-Schild, Stefan Tenzer, Hansj?rg Schild, Krishnaraj Rajalingam . Mainz, Germany.
- Shilei Ding, 2021. SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells . Journal: Viruses. Authors: Shilei Ding, Damien Adam, Guillaume Beaudoin-Bussi?res, Alexandra Tauzin, Shang Yu Gong, Romain Gasser, Annemarie Laumaea, Sai Priya Anand, Anik Priv?, Catherine Bourassa, Halima Medjahed, J?r?mie Pr?vost 1,3, Hugues Charest 5, Jonathan Richard 1,3, Emmanuelle Brochiero 1,2 and Andr?s Finzi 1,3,4,*. Montreal, Canada.
- Audrey Brisebarre, 2022. Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer. Journal: Frontiers in Immunology. Authors: Audrey Brisebarre, Julien Ancel, Th?ophile Ponchel, Emma Loeffler, Adeline Germain, V?ronique Dalstein, Val?rian Dormoy, Anne Durlach, Gonzague Delepine, Ga?tan Desl?e, Myriam Polette, B?atrice Nawrocki-Raby. Reims, France.
- M?lissa Aubin Vega, 2023. Impact of KvLQT1 potassium channel modulation on alveolar fluid homeostasis in an animal model of thiourea-induced lung edema. Journal: Frontiers in Physiology. Authors: M?lissa Aubin Vega, Alban Girault, Damien Adam, Jasmine Chebli, Anik Priv?, ?milie Maill?, Annette Robichaud, Emmanuelle Brochiero. Montreal, Canada.
- Ruth A. Elderfield, 2015. Ferret airway epithelial cell cultures support efficient replication of influenza B virus but not mumps virus. Journal: Journal of General Virology. Authors: Ruth A. Elderfield, Lauren Parker, Peter Stilwell, Kim L. Roberts, Silke Schepelmann, Wendy S. Barclay. London, UK.
Related Products
Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Complementary | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CnT Accutase Cell Detachment Solution | CnT-Accutase-100 | CELLnTEC | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CnT-CRYO Defined, Animal Component-Free Freezing Medium | CnT-CRYO-50 | CELLnTEC | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CnT Gentamycin / Amphotericin B Solution, 500 x, Ready-to-Use Single Aliquots | CnT-GAB10 | CELLnTEC | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differentiation 2D & 3D | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CnT-Prime Airway Epithelial 2D/3D Differentiation Medium | CnT-PR-AD | CELLnTEC | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Isolation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CnT Dispase II, Neutral Protease | CnT-DNP-10 | CELLnTEC | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CnT-IsoBoost, Isolation Boosting Supplement | CnT-ISO-50 | CELLnTEC | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proliferation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CnT-Prime Airway Epithelial Proliferation Medium | CnT-PR-A | CELLnTEC | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||